"This is a major milestone in the endless quest to prevent and treat neurodegenerative diseases like dementia and Alzheimer's disease. We're so happy to be able to provide hope for current sufferers and their families, as well as a solution to prevent future disease, using a scientifically-designed and scientifically-tested nutritional supplement," said Frederic J. Jouhet, founder of Memory Health LLC.
The prevention and treatment of neurodegenerative diseases is a global challenge, impacting several sectors worldwide, including corporations, state and federal governments, pharmaceutical companies, health insurance providers, hospital and healthcare networks, medical experts, and patients and their families. With a global aging population and a lack of available preventative options or curative treatments, these brain disorders will soon become a worldwide health crisis.
"This patent granted in the United Kingdom to a group of relentless researchers in the space of nutrition for the eyes and the brain is the first ray of hope in the fight for better brain health," added Jouhet. "This product gives us a road map to determine the exact nutritional deficiencies that cause degenerative brain conditions like dementia and Alzheimer's. And it provides a scientifically-designed supplement to remedy that shortage of nutrients in our daily diets."
Memory Health is the sole licensee for the patented formulation, which is used in its Memory Health brain health supplement. A U.S. patent is pending.
"This is real science proving real results for real people,” added managing partner Edward Shehab. “This second patent continues to validate the true efficacy of our product versus other so-called 'industry leaders' with less science but larger advertising budgets. Everybody claims to have success, but our success has been proven by clinical research trials, published in highly-respected medical journals and further validated with this latest patent.”